Mutational Analysis

Mutational Analysis Services

  • We develop molecular strategies by designing and executing assays for mutational analysis
  • Technologies include real-time PCR (Taqman, SYBR, and other chemistries) and Sanger sequencing of amplified nucleic acids
  • Our expertise in pathologist-directed recovery of nucleic acid from frozen and FFPE samples by macro dissection of tumors from slides enables us to use multiple platforms to identify and characterize mutations

In addition to developing and optimizing real-time PCR assays for individual client needs, the availability of our BioMark™ HD and nCounter® systems makes it possible to conduct high-throughput mutational analysis of research and clinical trial samples.

Ajay Pandita, DVM, PhD
Ajay Pandita, DVM, PhD
Chief Scientific Officer